{
    "nctId": "NCT03238053",
    "briefTitle": "Laser Treatment of Genito-urinary Syndrome in Women",
    "officialTitle": "Laser Treatment of Genito-urinary Syndrome in Women With Breast and Endometrial Cancer and Menopausal Women",
    "overallStatus": "WITHDRAWN",
    "conditions": "Laser-Induced Scar, Breast Cancer, Endometrial Cancer, Menopause, Vaginal Atrophy, Bladder, Overactive",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Visual analogue score on vaginal symptoms",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* menopause i.e. age more than 50 years and absence of menstruation for twelve months\n* breast cancer\n* endometrial cancer\n* symptoms of vaginal dryness\n* dyspareunia rated as moderate or severe most bothersome symptoms\n\nExclusion Criteria:\n\n* use of vaginal moisturizers, lubricants or any other local preparation within the thirty days prior to inclusion\n* acute or recurrent urinary tract infections\n* active genital infections i.e. herpes genitalis, candida\n* previous reconstructive pelvic surgery\n* pelvis organ prolapse stage 2\n* any serious disease or chronic condition that could interfere with study compliance except from breast and endometrial cancer\n* psychiatric disorders precluding informed consent",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}